Asthma medication data for the 24-month study period
| Variable | SABA-free (MART only) | SABA/MART | p value |
|---|---|---|---|
| BUD/FORM cannisters (n = mean/year ± SD) | 4.9 ± 1.8 | 7.68 ± 2.9 | 0.00347 |
| Steroid dose (mcg) mean (95% CI) (BDP equivalent) | 156.78 (60–274) | 317.21 (98–759) | < 0.001 |
It shows that the SABA-free group used significantly fewer BUD/FORM inhalers with an overall significantly lower steroid dose than the SABA/MART group. p < 0.05 is classed as statistically significant. SABA: short-acting β2-agonist; MART: maintenance and reliever therapy; BUD/FORM: budesonide/formoterol; BDP: beclomethasone dipropionate